NCT02425839

Brief Summary

Diagnoses and follow up of muscles diseases lack imaging. Severity assessment of masticatory dysfunction and follow up of treatment effectiveness is currently based only on clinical features. Supersonic ShearWave Imaging® is a new, non-invasive, non-irradiating and dynamic imaging technique that uses ultrasound and allows shear wave elastic modulus in a muscle in order to study its viscoelastic properties. In this study, the investigators study the correlation between changes of shear wave elastography modulus and surface electromyogram features of the masseters between rest and maximal voluntary contraction.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started May 2015

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 9, 2015

Completed
15 days until next milestone

First Posted

Study publicly available on registry

April 24, 2015

Completed
7 days until next milestone

Study Start

First participant enrolled

May 1, 2015

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2015

Completed
Last Updated

November 6, 2015

Status Verified

November 1, 2015

Enrollment Period

Same day

First QC Date

April 9, 2015

Last Update Submit

November 5, 2015

Conditions

Keywords

shear wave elastographysurface electromyogrammasseter

Outcome Measures

Primary Outcomes (1)

  • Elastic modulus using Supersonic Shear Imaging® technique on superficial and deep masseter parts at rest and maximal voluntary contraction.

    Day 1 (inclusion day)

Secondary Outcomes (3)

  • Thickness of the whole masseter mesured by Supersonic Shear Imaging® technique

    Day 1 (inclusion day)

  • Thickness of the masseter superficial part mesured by Supersonic Shear Imaging® technique

    Day 1 (inclusion day)

  • Thickness of the masseter deep part mesured by Supersonic Shear Imaging® technique

    Day 1 (inclusion day)

Study Arms (1)

Experimental group

EXPERIMENTAL

* ultrasound exam by Supersonic Shear Imaging® technique * EMG examination by electromyograph Keypoint system.

Device: Ultrasound exam by Supersonic Shear Imaging® techniqueDevice: EMG examination by electromyograph Keypoint system

Interventions

Each of the two observers performs twice ultrasound examination and measures of the masseter thickness and its elastic modulus, at rest and maximal voluntary contraction.

Experimental group

Experimented neurologist performs EMG examination.

Experimental group

Eligibility Criteria

Age20 Years - 40 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • People with social security.
  • People aged 20 to 40 years, of both sexes.
  • People that gave and signed consent to participate in the study.

You may not qualify if:

  • Any concomitant muscle disease (myopathy, myositis…)
  • Botulinum toxin injections in the masseter in the last 3 months preceding the study.
  • Any treatment that induces muscular effect (baclofen, benzodiazepine)
  • Bruxism or any masticatory apparatus disease
  • Any surgery of the masticatory apparatus

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU de Saint-Etienne

Saint-Etienne, 42055, France

Location

MeSH Terms

Conditions

Trismus

Condition Hierarchy (Ancestors)

SpasmNeuromuscular ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Claire BOUTET, MD

    CHU de SAINT-ETIENNE

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 9, 2015

First Posted

April 24, 2015

Study Start

May 1, 2015

Primary Completion

May 1, 2015

Study Completion

May 1, 2015

Last Updated

November 6, 2015

Record last verified: 2015-11

Locations